| Patient | David Hume |
|---|---|
| Date of birth | 1962-05-07 |
| Identifiers | MRN HR-EN012-SYN; SSN (made up) 000-12-3049 |
| Document date | 2026-06-01 |
| Author | Fiona Gallacher, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Review of colonoscopy, biopsy, and staging results. [S]
Mr. Hume returns three weeks after presenting with looser stools, dark blood, tiredness, and iron deficiency anemia. Colonoscopy thirteen days ago reached the cecum and found a 4 cm ulcerated mass at 28 cm in the sigmoid colon, which was biopsied and tattooed; there were no other lesions. The biopsy shows moderately differentiated adenocarcinoma with intact mismatch-repair proteins. The staging CT eleven days ago showed two small pericolic lymph nodes, clear lungs, and one 9 mm indeterminate lesion in the liver. He still has two or three loose stools a day with dark blood on some days, and he tires on hills. His weight is down a further 0.8 kg. He saw Dr. Mehta of medical oncology this morning and has a colorectal surgery appointment this week. He took the news calmly and asked for the facts plainly; he wants to keep working on his books. [S]
| Element | Detail |
|---|---|
| Interval change | Diagnosis confirmed by biopsy; staging CT done |
| Bowel symptoms | Two or three loose stools a day; dark blood on some days |
| Weight | Down 0.8 kg in three weeks |
| Function | Tires on hills; working at his desk each morning |
| Coordination | Medical oncology seen today; colorectal surgery this week |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tiredness; weight loss; no fever or night sweats |
| Gastrointestinal | Positive | Loose stools with dark blood on some days; no abdominal pain, distension, or vomiting |
| Cardiovascular | Negative | No chest pain or palpitations at rest |
| Respiratory | Negative | Breathless only on steep hills |
| Genitourinary | Negative | No urinary symptoms |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ferric carboxymaltose 750 mg intravenous infusion, two doses one week apart | 750 mg IV once a week for two doses | Intravenous route | 2026-06-01 to 2026-06-08 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-01 | Body height | 178 | cm | S |
| 2026-06-01 | Body weight | 87.2 | kg | S |
| 2026-06-01 | Body mass index (BMI) [Ratio] | 27.5 | kg/m2 | S |
| 2026-06-01 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-06-01 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-06-01 | Heart rate | 88 | /min | S |
| 2026-06-01 | Respiratory rate | 16 | /min | S |
| 2026-06-01 | Body temperature | 36.7 | Cel | S |
| 2026-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-01 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma | 6.4 | ng/mL | <=3 ng/mL | High | S |
| 2026-06-01 | Hemoglobin [Mass/volume] in Blood | 10.3 | g/dL | 13.2-16.6 g/dL | Low | S |
| 2026-06-01 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-55 U/L | Normal | S |
| 2026-06-01 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 8-48 U/L | Normal | S |
| 2026-06-01 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 88 | U/L | 40-129 U/L | Normal | S |
| 2026-06-01 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.6 | mg/dL | 0.1-1.2 mg/dL | Normal | S |
Vital signs recorded on 2026-06-01; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Comfortable, pale |
| Eyes | Conjunctival pallor |
| Abdomen | Soft, non-tender; no palpable mass; liver not enlarged; no ascites |
| Lymph nodes | No supraclavicular or inguinal nodes |
| Cardiovascular | Regular rhythm, heart rate 88; soft flow murmur |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Adenocarcinoma of the sigmoid colon, suspected at presentation and confirmed by colonoscopic biopsy; synthetic modern diagnosis linked to the documented 1775 bowel disorder and its retrospective interpretation as colon cancer | active | confirmed | C18.7 | S — Synthetic diagnosis confirmed by biopsy and resection in the modern episode; the historical diagnosis remains a retrospective interpretation (R). |
| Iron deficiency anemia from chronic blood loss from the colon tumor | active | confirmed | D50.0 | S — Synthetic finding echoing the documented 'hemorrhage in the upper part of the intestines'; no blood count from his lifetime exists. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | CEA, preoperative baseline | Once before resection | Completed today | 6.4 ng/mL, raised |
| Laboratory | Liver tests at staging (ALT, AST, alkaline phosphatase, bilirubin) | At staging | Completed today | All normal |
| Laboratory | Hemoglobin before intravenous iron | Before treatment | Completed today | 10.3 g/dL |
| Imaging | CT of the chest, abdomen, and pelvis | At staging | Up to date | Done eleven days ago: two pericolic nodes up to 7 mm, clear lungs, one indeterminate 9 mm liver lesion |
| Imaging | MRI of the liver | When CT shows an indeterminate liver lesion | Ordered | Booked in three days |
| Examination | Complete colonoscopy before resection | At diagnosis | Up to date | Reached the cecum thirteen days ago; no other lesions, so the first surveillance colonoscopy will be due one year after resection |
| Laboratory | Mismatch-repair testing of the tumor | At diagnosis, for every colorectal cancer | Up to date | MLH1, PMS2, MSH2, and MSH6 intact on the biopsy (mismatch-repair proficient) |
| Referral | Medical oncology | At diagnosis | Completed today | Seen this morning; recommendations in the consultation note |
| Referral | Colorectal surgery | At diagnosis | Referred | Appointment this week |
| Medication safety | Intravenous iron infusion | Each dose | Completed today | First 750 mg dose given with 30 minutes of observation; no reaction |
| Laboratory | Blood count and ferritin after intravenous iron | 6 to 8 weeks after infusion | Due | At the postoperative visit |
| Survey | Distress and depression screen (PHQ-2) | At each follow-up visit | Deferred | Not done today, the visit at which the diagnosis and plan were discussed, a deviation from the CMID schedule. He appeared composed and asked for plain facts; screening is added to the postoperative visit |
Goal progress:
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Colon Cancer, Version 4.2025 (2025); AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia (2020); CMID: Clinical Monitoring Intelligence Database, colorectal cancer and anemia monographs (2026)
Follow-up: MRI of the liver in three days. Second iron infusion in one week. Colorectal surgery this week. Primary care review about four weeks after surgery. Next scheduled visit 2026-07-13: review four weeks after laparoscopic sigmoid colectomy, before adjuvant chemotherapy. [S]